United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 5, 2026 · Filed Oct 6, 2026

On Oct 5, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$541.64 for US$5.15M under a trading plan, leaving 324,443 shares. Filed Oct 6, 2026 (Form 4).

Sold
9,500 shares
Price
US$541.64 average (US$536.26 to US$546.63)
Value
US$5.15M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 5, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 5, 2026Common StockSale501US$536.26333,442Indirect
Oct 5, 2026Common StockSale905US$537.43332,537Indirect
Oct 5, 2026Common StockSale655US$538.62331,882Indirect
Oct 5, 2026Common StockSale931US$539.50330,951Indirect
Oct 5, 2026Common StockSale1,028US$540.50329,923Indirect
Oct 5, 2026Common StockSale1,239US$541.66328,684Indirect
Oct 5, 2026Common StockSale918US$542.56327,766Indirect
Oct 5, 2026Common StockSale783US$543.54326,983Indirect
Oct 5, 2026Common StockSale1,260US$544.59325,723Indirect
Oct 5, 2026Common StockSale920US$545.69324,803Indirect
Oct 5, 2026Common StockSale360US$546.63324,443Indirect

Source

View original at SEC

Related